FDA product code · Immunology

Colostrum, Antigen, Antiserum, Control

Name: FDA decisions, review times, recalls and adverse event reports for product code DGJ
Creator: 510(k) Report

DGJClass I21 CFR 866.5230510(k) exempt1 decision since 19890 recalls

FDA lists DGJ as exempt from 510(k): a device of this type needs no clearance unless one of the limits in 21 CFR 866.9 applies, such as a new intended use or a different fundamental technology. 1 FDA decision since 1989. No recall names this code.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, immunology panel

Twenty years of DGJ at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · DGJ

FDA has decided no DGJ device since 2007.

Median 510(k) review, days · DGJ

Too few DGJ 510(k)s in any year since 2007 to give a median.

Recalls per year · DGJ

No recall names DGJ since 2007.

Adverse event reports per year · DGJ

No MAUDE report names DGJ since 2007.

View these four charts as a table

Year	Median 510(k) review, days	MAUDE reports
2007	—	0
2008	—	0
2009	—	0
2010	—	0
2011	—	0
2012	—	0
2013	—	0
2014	—	0
2015	—	0
2016	—	0
2017	—	0
2018	—	0
2019	—	0
2020	—	0
2021	—	0
2022	—	0
2023	—	0
2024	—	0
2025	—	0
2026	—	—

FIG. 1 — DGJ by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in DGJ? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Colostrum, Antigen, Antiserum, Control

What has FDA decided in DGJ lately?